MENU
+Compare
VTAK
Stock ticker: ASE
AS OF
Jun 6 closing price
Price
$0.21
Change
-$0.00 (-0.00%)
Capitalization
3.41M

VTAK Catheter Precision Forecast, Technical & Fundamental Analysis

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP... Show more

VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VTAK with price predictions
Jun 06, 2025

VTAK in upward trend: price may ascend as a result of having broken its lower Bollinger Band on May 23, 2025

VTAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 48 cases where VTAK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VTAK's RSI Indicator exited the oversold zone, of 55 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where VTAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTAK advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VTAK as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VTAK turned negative on May 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VTAK entered a downward trend on May 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.160) is normal, around the industry mean (24.242). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (6.770) is also within normal values, averaging (42.497).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VTAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of excimer lasers for the treatment of dermatologic and cardiovascular diseases

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1670 Highway 160 West
Phone
+1 973 691-2000
Employees
14
Web
https://www.ramed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH18.850.28
+1.51%
Dianthus Therapeutics
ZVSA0.650.01
+1.50%
ZyVersa Therapeutics
ONON56.56-0.39
-0.68%
On Holding AG
GH48.06-0.35
-0.72%
Guardant Health
CATO2.56-0.07
-2.66%
CATO Corp

VTAK and Stocks

Correlation & Price change

A.I.dvisor tells us that VTAK and PRPO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and PRPO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTAK
1D Price
Change %
VTAK100%
+3.22%
PRPO - VTAK
27%
Poorly correlated
-1.50%
BLFS - VTAK
25%
Poorly correlated
+10.28%
SGHT - VTAK
25%
Poorly correlated
N/A
CSTL - VTAK
25%
Poorly correlated
+3.41%
CERS - VTAK
25%
Poorly correlated
+9.42%
More